UC Berkeley’s cancer therapy developer priced a $304m initial public offering at the top of its range.

ArcelorMittal led a series D round for the rechargeable battery developer spun out of MIT.

The NFT marketplace, which counts Stanford-StartX Fund as an investor, has raised series B funding led by Andreessen Horowitz.

Yale University is in line to exit proteomics platform developer IsoPlexis in a Nasdaq Global Market offering with a $100m placeholder target.

The Oxford-backed corporate education resource provider’s overall funding now stands at more than $280m.

Several corporates helped the Montana State University-backed microbial protein developer take its total funding above $500m.

The UChicago-backed digital home insurance provider is joining forces with Omnichannel Acquisition Corp at a valuation of just over $1bn.

Harvard spinout TScan Therapeutics has successfully listed on the Nasdaq Global Market.

Osage University Partners has returned to back the cancer and inflammatory drug developer based on research from multiple universities.

WUSTL spinout Wugen has collected $172m in a series B round to progress its pipeline targeting several cancer indications.